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Purpose. Alveolar osteitis is the most common post-odontectomy 
complication. Although blood clot disintegration is known to be the cause of 
the condition, an agreement is lacking regarding a treatment of choice. The 
aim of the current study therefore was to evaluate major autohemotherapy 
as one treatment method.
Patients and Methods. A total of 183 patients were categorized into 4 
groups (I, II, III, and IV) according to pain severity (mild, moderate, severe, 
or agonizing, respectively). Major autohemotherapy was performed for all 
patients by withdrawing 225 mL of patient's blood and mixing them with 
225_mL of Oxygen-Ozone gas (where Ozone concentration was 50 µg/mL 
gas).
Results and Discussion. Despite autohemotherapy was a high-potency 
curative treatment for groups I and II, it was palliative for group IV. For group 
III, it oscillated between being a curative or a palliative treatment with a 
statistically insignificant difference.
Conclusions. Autohemotherapy might be a recommended treatment for 
alveolar osteitis. 
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Introduction 
Alveolar osteitis (AO) is a very common complication of dental 
extraction [1]. Although Birn’s suggestion [2] that AO results from 
blood clot disintegration has gained wide acceptance, the exact 
etiology is still poorly understood [3,4]. Pain is the most important 
aspect of AO according to Fazakerlev and Field [5], and although a 
variety of treatment methods have been attempted to treat or alleviate 
this pain, considerable controversy exists regarding their relative 
efficacies [3,6,7]. Ozone is a very powerful healer and oxidant [8–13]. 
Since Wolff has introduced Ozone major Autohemotherapy (AHT) was 
a frequently used treatment method for a variety of conditions [14]. 
AHT enhances oxygen delivery to ischemic tissues, and in turn, 
improves general metabolism and activates the immune system as 
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Literature, up to the best of my knowledge, is deprived of any studies 
for the effect of AHT (as a systemic form of Ozone application) in AO 
patients. The aim of the current study was to evaluate the efficacy of 
AHT as a treatment method for AO utilizing definitive parameters for 
diagnosis and outcome assessment taking in consideration that AO 
treatment is pain relief-targeted rather than healing-targeted.
Patients and methods 
The author examined patients in the Hosh Isa district (Al-Behera, 
Egypt) who presented with pain after dental extraction during the 
years 2004 through 2010. Patients diagnosed with AO (“dry socket”) 
fulfilling inclusion criteria were divided into 4 groups according to pain 
severity (Table 1).
All patients underwent brief saline irrigation of the socket with 2 mL 
normal saline (0.9% solution) to remove any debris. Major 
Autohemotherapy was carried out by withdrawing 225 mL of patient's 
blood by vacuum from an antecubital vein into a sterile glass bottle 
(Ozonosan, Iffezeim, Germany) containing 25 mL of 3.8% Sodium 
Citrate solution (Alamia gp, Cairo, Egypt) as an anticoagulant. Then 
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Table 1: Pain severity levels used to assign patients to groups
Severity of Pain Description
I Mild Patients had annoying or bothering pain during most 
awakening hours but did not need analgesics. 
II Moderate Patients had pain that required and was relieved by 
analgesics (a maximum of three "bills" per day of the 
analgesic type that is usually taken by the patient).
III Severe Patients had pain that was not relieved by analgesics (a 
maximum of three "bills" per day of the analgesic type that 
is usually taken by the patient) but that did not interfere with 
normal daily activities (e.g., patients did not have to leave 
work and did not awaken during sleep).
IV Agonizing Patients had pain that was not relieved by analgesics (a 
maximum of three "bills" per day of the analgesic type that 
is usually taken by the patient) and that interfered with 
normal daily activities (e.g. the pain caused the patients to 
leave work or to awaken during the night).
JO3TMosaad Abdaljawwad Khalifah 
by a saline infusion. Blood was then continuously mixed with 225 mL 
of Oxygen-Ozone gas (where Ozone concentration was 50 µg/mL gas 
with a total dose of Ozone equivalent to 11.25 mg) produced by an 
Ozonline 80 E generator (Medica srl, Bologna, Italy). Mixing was for at 
least 5 minutes with a concomitant gentle rotatory movement in order 
to avoid foaming. Then blood is reinfused over 15-20 minutes after 
disconnecting saline infusion. The whole system is Ozone-resistant 
[13,15]. AHT was performed every three days if pain was not 
eliminated.
This study complied with the Declaration of Helsinki, and the regional 
ethical review board of the research unit at Hosh Isa Medical Center 
approved the study.
Inclusion criteria:
1.  Pain after simple dental extraction (forceps extraction)
2.  Diagnosis of AO (dry socket) 
3.  Age 25 to 55 years.
Exclusion criteria:
1. Signs or symptoms of an infected socket.
2. Systemic or local conditions hindering or otherwise affecting 
healing.
3. Disorders causing bleeding tendencies.
4. Tooth extraction during menstruation.
5. Pregnancy, lactation, or use of oral contraceptives.
6. Hormonal disturbances.
7. Smoking.
The effectiveness of the treatment modality in pain alleviation was 
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Table 2: Parameters for assessing treatment effectiveness
Designation Criteria
Curative Treatment was followed by disappearance of pain without 
other medication (or pain became too slight to be annoying 
or to lead the patient to seek medical or dental intervention).
Palliative Treatment was followed by decreased pain severity but pain 
remained at least annoying, or treatment was followed by a 
decrease in the dose of analgesics taken, or both.
Ineffective Treatment was not followed by noticeable diminution in pain 
severity (and pain remained at least annoying), or the 
treatment had a palliative effect that was not maintained to 
the end of a 5- minute visit.
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The total time needed for the patient not to seek medical or dental 
intervention was recorded for each group in order to assess 
effectiveness of the treatment applied. The potency of treatment 
modality was considered high if that period was 2 days or less, 
moderate if it was 3 or 4 days, and low if it was 5 days or more, as the 
total healing period typically ranges from 7 to 10 days [4]. If the 
curative effect was achieved within 1 day, thus requiring only a single 
application, the treatment was considered a definitive therapy.
Results 
A total of 183 patients were included in the current study. The numbers 
of patients in groups I, II, III, and IV were 56, 78, 36, and 13, 
respectively. The effectiveness of AHT in each group is shown in 
Table_3, while tables 4 and 5 depict the potency. N.B.: the palliative, 
ineffective, palliative/ineffective (when the difference in-between was 
statistically insignificant) and curative/palliative (when the difference 
in-between was statistically insignificant) results could be collectively 
termed as noncurative.
AHT was a curative treatment method of a high potency in groups I 
and II. However, it was definitive therapeutic measure only for group I 
patients. Results of AHT in group III oscillated between being curative 
and palliative with a statistically insignificant difference. Furthermore, 
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Table 3: Number of patients allocated for each effect in each group and the decision 
according to the statistical analysis.
Numbers for each 
AHT effect *
Decision Fisher's exact test
C P In
Group I 55 1 0 C P<0.001 (significant difference)
Group II 74 3 1 C P<0.001 (significant difference)
Group III 21 15 0 C/P P=0.41 (insignificant difference)
Group IV 1 10 2 P P=0.003 (significant difference 
between curative and noncurative 
results), P=0.039 (significant 
difference between P and In results)
* AHT (Major Autohemotherapy) Effect: C=curative, P=palliative, In=ineffective, C/P= 
curative or palliative with the difference being statistically insignificant
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Discussion 
In order to study as homogenous group of patients as possible, the 
study population was restricted to otherwise healthy patients who 
underwent simple (forceps) extraction and did not have any known 
conditions affecting their healing capacities, since AO seems to reflect 
an interference with the healing process, resulting in blood clot loss 
[2]. The inclusion and exclusion criteria were determined accordingly.
To my knowledge, no published studies of AO treatment have 
classified patients according to pain severity or analyzed the outcome 
according to definitive assessment criteria. However, in the current 
study, patients were categorized into 4 major groups according to pain 
severity. The severity rating was not based on the patient’s description 
(for example, use of words like "mild" or "severe") or on the patient’s 
estimation on a visual pain analogue scale; rather, it relied on 
behavioral measures: the need for analgesics and whether the 
condition interfered with daily life. On assessing the outcome of 
treatment methods in the current study, only 3 possibilities, all well-
defined, were considered. These features, in addition to the size of the 
population, appear unique to the current study.
In the current research, AHT demonstrated a graded therapeutic effect 
through groups I to IV. Its highest level of potency was shown in group 
I where it acted as a definitive high-potency curative treatment 
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Table 4: Potency of the curative effect.
Gr * 1 day 2 days 3 days 4 days 5 days Median Potency
Test of 
difference





II 20 29 11 10 4 2 High
* Gr=group, ¶ Mann Whitney U test
Table 5: Determination if AHT was a definitive therapy or not.
Group 1 day (once) ˃1 day P value* Decision
I 42 13 <0.001 definitive
II 20 54 <0.001 not definitive
* P value for Fisher's exact test
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furthermore, it was least effective in higher severity groups (groups III 
and IV) to end to be only palliative in group IV. Despite of that 
spectrum, AHT might be considered an accepted modality reflecting 
the healing capability of systemic Ozone in AO patients.
Results of the current study might follow the same stream of other 
studies indicated that AHT is a powerful healer [8–11,13]. However, 
AHT was not intended or assessed as a healer, but rather, treating 
pain was the target. AHT increases oxygen delivery to ischemic 
tissues improving general metabolism and activating the immune 
system [8–11, 13]. Compressive stresses delivered to alveolar socket 
walls due to extraction forces might lead to a state of ischemia. Lactic 
acid produced by anaerobic glycolysis that prevails during ischemia in 
addition to other noxious substances might be causes for blood clot 
disintegration and for nerve irritation and therefore pain. Reversing 
that ischemia and washing out the noxious substances by reperfusion 
in addition to ceasing anaerobic glycolysis by the high oxidative power 
of Ozone could be a probable mechanism for the therapeutic effect of 
AHT.
Conclusions 
Alveolar osteitis results from blood clot disintegration. Until now, there 
has been no generally agreed on treatment of choice. In the current 
prospective study, AHT was assessed as a potential treatment. AHT 
showed a graded therapeutic effect as it was definitive high-potency 
curative treatment method for group I and was only palliative for group 
IV patients. It might cause reversal of the ischemic condition that could 
develop as a result of compressive stresses during dental extraction. 
AHT could be recommended as one treatment modality for AO for mild 
and moderate pain patients.
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